LDLR and familial hyperaldosteronism: The functionality of four variants identified in the literature6 in patients with a diagnosis of heterozygous FH within the LDLR 5′UTR (c.-13A>G) or promoter (c.-101T>C, c.-121T>C and c.-215A>G) were analysed using in silico and in vitro assays.